Literature DB >> 35308763

Extra-Axial Skeletal Metastasis of Malignant Melanoma: Case Report and Literature Review.

Keerthi Gullapalli1, Priyal Agarwal1, Osama Mosalem1, Venumadhavi Gogineni1, Richa Tikaria1.   

Abstract

The incidence of malignant melanoma is increasing worldwide and is one of the major causes of skin cancer deaths in the United States. Although melanoma has the potential to metastasize to any organ, the incidence of bone metastasis is low (~25%) compared to liver or lung metastasis. However, when a bone is involved, metastasis occurs to the axial skeleton in most cases (80%-90%), and involvement of the appendicular skeleton is relatively rare. We here describe the case of a patient who presented with a pathological fracture due to extra-axial skeletal metastasis of a widespread malignant melanoma.  A 45-year-old female with an unremarkable past medical history presented to the ED with acute left hip pain. X-ray demonstrated left intertrochanteric femur fracture with an abnormal, suspicious lesion at the fracture site. Detailed physical examination revealed various skin nodules on the anterior chest wall, right upper back, and left cheek. CT of the chest/abdomen/pelvis (CT C/A/P) showed multiple lytic bone lesions and metastatic lesions in lungs, soft tissue, and mediastinal lymph nodes. She underwent surgical stabilization of the fracture, and a biopsy of the bone lesion revealed metastatic malignant melanoma with BRAF V600E mutation. She was started on localized radiotherapy followed by targeted therapy (dabrafenib and trametinib) and denosumab for her stage IV (cTX, cN2, cM1b(1)) (American Joint Committee on Cancer [AJCC] cancer staging 8th edition) disease. Despite treatment, her disease progressed as evidenced by the presence of new metastatic foci on a positron emission tomography-computed tomography (PET-CT) scan performed at a three-month follow-up. Her clinical course was complicated by hemoperitoneum due to bleeding from metastatic liver lesions and respiratory failure requiring a prolonged stay in the ICU before she was deceased. In most cases, malignant melanoma presents with skin lesions at an early stage. Very few patients (4%) have metastatic disease at presentation. Although metastasis to bone is known to occur in advanced disease, involvement of the extra-axial skeleton is relatively rare. Malignant melanoma, initially presenting as pathological fracture of the appendicular skeleton, is not commonly encountered. Our case emphasizes the aggressive nature of malignant melanoma with an aim to raise physicians' awareness of this uncommon presentation. A brief review of the literature exploring prognosis and currently available treatment options is discussed.
Copyright © 2022, Gullapalli et al.

Entities:  

Keywords:  appendicular skeletal metastasis; braf mutation; dabrafenib; denosumab; extra-axial metastasis; immunotherapy; malignant melanoma; pathological fracture; skeletal related events; trametinib

Year:  2022        PMID: 35308763      PMCID: PMC8920794          DOI: 10.7759/cureus.22115

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

Review 1.  Pathophysiology of bone metastases.

Authors:  James R Berenson; Lakshmi Rajdev; Michael Broder
Journal:  Cancer Biol Ther       Date:  2006-09-20       Impact factor: 4.742

2.  Metastatic Melanoma in the Femur - Case Report with Review of Literature: a Pathologist's Point of View.

Authors:  Mariana Costache; Alexandra Stoica; Andreea Contolenco; Diana Costache; Catalin Cirstoiu; Olga Simionescu; Simion George
Journal:  Maedica (Buchar)       Date:  2014-03

3.  Pathologic fracture of the distal tibia secondary to melanoma: A case report of a very rare entity.

Authors:  M Herrera-Perez; A Ayala-Rodrigo; P Sanchez-Hernandez; L M Rodriguez-Rodriguez
Journal:  Foot Ankle Surg       Date:  2011-11-18       Impact factor: 2.705

4.  An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival.

Authors:  Francesco Mannavola; Mario Mandala; Annalisa Todisco; Vanna Chiarion Sileni; Marco Palla; Alessandro Marco Minisini; Laura Pala; Francesca Morgese; Lorenza Di Guardo; Luigia Stefania Stucci; Michele Guida; Alice Indini; Pietro Quaglino; Virginia Ferraresi; Riccardo Marconcini; Maria Chiara Tronconi; Ernesto Rossi; Olga Nigro; Marcella Occelli; Alessio Cortellini; Silvia Quadrini; Giuseppe Palmieri; Jacopo Pigozzo; Paolo Antonio Ascierto; Maria Grazia Vitale; Sabino Strippoli; Pier Francesco Ferrucci; Rossana Berardi; Giovanni Randon; Pietro Cardone; Giovanni Schinzari; Franco Silvestris; Marco Tucci
Journal:  Front Oncol       Date:  2020-09-15       Impact factor: 6.244

Review 5.  Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy.

Authors:  U Laggner; J S Lopez; G Perera; V S Warbey; A Sita-Lumsden; M J O'Doherty; A Hayday; M Harries; F O Nestle
Journal:  Clin Immunol       Date:  2009-02-27       Impact factor: 3.969

6.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702

Review 7.  Bone Metastases: An Overview.

Authors:  Filipa Macedo; Katia Ladeira; Filipa Pinho; Nadine Saraiva; Nuno Bonito; Luisa Pinto; Francisco Goncalves
Journal:  Oncol Rev       Date:  2017-05-09

Review 8.  Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Anne Rogiers; Annelies Boekhout; Julia K Schwarze; Gil Awada; Christian U Blank; Bart Neyns
Journal:  J Oncol       Date:  2019-04-28       Impact factor: 4.375

9.  Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma.

Authors:  Amod A Sarnaik; Omid Hamid; Nikhil I Khushalani; Karl D Lewis; Theresa Medina; Harriet M Kluger; Sajeve S Thomas; Evidio Domingo-Musibay; Anna C Pavlick; Eric D Whitman; Salvador Martin-Algarra; Pippa Corrie; Brendan D Curti; Judit Oláh; Jose Lutzky; Jeffrey S Weber; James M G Larkin; Wen Shi; Toshimi Takamura; Madan Jagasia; Harry Qin; Xiao Wu; Cecile Chartier; Friedrich Graf Finckenstein; Maria Fardis; John M Kirkwood; Jason A Chesney
Journal:  J Clin Oncol       Date:  2021-05-12       Impact factor: 50.717

Review 10.  Melanoma epidemiology, biology and prognosis.

Authors:  Z Ali; N Yousaf; J Larkin
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.